Cleidocranial dysostosis: Difference between revisions

From WikiMD's Medical Encyclopedia

No edit summary
 
CSV import
Tags: mobile edit mobile web edit
Line 26: Line 26:
{{stub}}
{{stub}}
{{rarediseases}}
{{rarediseases}}
<gallery>
File:Marie_et_Sainton_1.jpg|Cleidocranial dysostosis
File:Marie_et_Sainton_2.jpg|Cleidocranial dysostosis
File:Cleidocranial2.jpg|Cleidocranial dysostosis
File:Cleidocranial_dysplasia_teeth.jpg|Cleidocranial dysplasia teeth
File:Cleidocranial.jpg|Cleidocranial dysostosis
</gallery>

Revision as of 04:59, 18 February 2025

Cleidocranial dysostosis (CCD), also known as Cleidocranial dysplasia, is a rare genetic disorder primarily affecting bone and dental development. It is inherited in an autosomal dominant manner, typically resulting from mutations in the RUNX2 gene<ref>,

 Cleidocranial dysplasia, 
 Orphanet Journal of Rare Diseases, 
 2006,
 Vol. 1(Issue: 1),
 pp. 15,
 DOI: 10.1186/1750-1172-1-15,
 PMID: 16722557,</ref>.

Clinical Presentation

Characteristics of CCD include skeletal and dental abnormalities. The most characteristic features are underdeveloped or absent clavicles (collar bones), which results in individuals being able to bring their shoulders together in front of their body. Dental anomalies, including delayed loss of primary teeth and delayed eruption of secondary teeth, are common. Other features include delayed or incomplete closure of the fontanelles, a prominent forehead, wide-set eyes (hypertelorism), a flat nose, and a short stature. Spinal abnormalities, such as scoliosis, may also occur<ref>,

 GeneReviews. online version, 
  
 University of Washington, Seattle, 
 2018,</ref>.

Genetics

CCD is caused by mutations in the RUNX2 gene, located on chromosome 6p21. RUNX2 is essential for the development of osteoblasts, the cells responsible for bone formation<ref>,

 CBFA1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, 
 Cell, 
 1997,
 Vol. 89(Issue: 5),
 pp. 765-771,
 DOI: 10.1016/S0092-8674(00)80259-7,
 PMID: 9182762,</ref>.

Diagnosis and Management

Diagnosis of CCD is primarily based on clinical examination and radiographic findings, but can be confirmed by genetic testing. Management of CCD is mainly supportive and involves a multidisciplinary approach, including orthopedic management for skeletal anomalies and dental interventions for oral health<ref>,

 Cleidocranial dysplasia: clinical and molecular genetics, 
 Journal of the American Dental Association, 
 1999,
 Vol. 130(Issue: 5),
 pp. 656-662,
 DOI: 10.14219/jada.archive.1999.0257,
 PMID: 10332264,</ref>.

See Also

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia

NIH genetic and rare disease info

Cleidocranial dysostosis is a rare disease.